GSK links with US research institute to study brain function

GlaxoSmithKline has teamed up with Sanford Burnham Prebys Medical Discovery Institute to study brain function and seek out new therapeutic targets for neurological disorders.   The SBP-GSK Center for Translational Neuroscience, located on the non-profit research orgnaisation’s campus in La Jolla, California, will bring together experts from both parties to investigate factors influencing brain function and potentially reverse or slow down neurodegeneration, with the aim of identifying and validating new therapeutic targets.    Under the three-year alliance, the UK-headquartered drugs giant will provide funding to create and support a research lab, to house SBP scientists, postdoctoral candidates and technicians working alongside neuroscientists from GSK.   Explaining the strategy behind the move, SBP highlighted the lack the effective therapies to prevent or treat dementia and other neurodegenerative conditions, and that just…


Link to Full Article: GSK links with US research institute to study brain function